When evaluating the concentration of tau protein in the saliva of participants, a reduction in the expression of t-tau and an increase in salivary p-Tau were observed in patients with a probable diagnosis of Alzheimer’s dementia, demonstrating the viability of using these biomarkers9. The gene discussed is MAPT; the disease is Alzheimer disease.